首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin.
【24h】

Unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignancies using a nonmyeloablative conditioning regimen of fludarabine, low-dose total body irradiation, and rabbit antithymocyte globulin.

机译:使用氟达拉滨,低剂量全身照射和兔抗胸腺细胞球蛋白的非清髓性治疗方案,对血液系统恶性肿瘤患者进行无关的供体造血干细胞移植。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Hematopoietic stem cell chimerism can be established after low-dose conditioning regimens, although the risk of donor cell rejection increases for unrelated donor transplantations. We added pretransplantation rabbit antithymocyte globulin (6 mg/kg) to an established conditioning regimen of fludarabine (90 mg/m 2 ) and single-fraction total body irradiation (200 cGy) followed by postgrafting immunosuppression with cyclosporine A and mycophenolate mofetil for 22 patients with hematologic malignancies. One patient rejected the graft and successfully underwent transplantation with cells from a second donor by using the same conditioning regimen. The actuarial probability of developing acute graft-versus-host disease grade II to IV before day 100 was 40%, although 9 of 14 patients who survived beyond 100 days developed chronic graft-versus-host disease. These data support a hypothesis that the addition of antithymocyte globulin decreases the risk of graft-versus-host and host-versus-graft reactionswhen combined with a nonmyeloablative conditioning regimen of fludarabine and total body irradiation.
机译:摘要低剂量条件治疗方案可以建立造血干细胞嵌合体,尽管不相关供体移植会增加供体细胞排斥的风险。我们将移植前的兔抗胸腺细胞球蛋白(6 mg / kg)添加到既定的氟达拉滨(90 mg / m 2)和单次全身照射(200 cGy)的条件治疗方案中,然后用环孢菌素A和霉酚酸酯进行免疫抑制后移植治疗22例患者血液系统恶性肿瘤。一名患者拒绝了移植物,并通过使用相同的调节方案成功地接受了第二名供体的细胞移植。在第100天之前发展为II至IV级急性移植物抗宿主病的精算机率是40%,尽管存活超过100天的14例患者中有9人发展为慢性移植物抗宿主病。这些数据支持以下假设:当与氟达拉滨的非清髓调节方案和全身照射相结合时,添加抗胸腺细胞球蛋白可降低移植物抗宿主反应和宿主抗移植反应的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号